Harris campaign silent on House bill targeting Chinese military ties

The House passed the Biosecure Act, HR 8333, with a significant majority, aiming to prohibit federal contracts with companies linked to the Chinese military, including the Beijing Genomics Institute (BGI). This legislation has raised concerns due to its implications for Governor Tim Walz, who has connections to an institute that has collaborated with BGI. The House Oversight Committee is currently investigating these ties, which have come under scrutiny amid broader concerns about Chinese influence in U.S. biotechnology and national security. Rep. Brad Wenstrup, the bill's sponsor, emphasized the need to reduce reliance on Chinese biotech firms, citing risks to American genetic data and national security. The bill's passage reflects growing bipartisan concern over the activities of Chinese companies in the U.S., particularly in sensitive sectors like biotechnology. The investigation into Walz's connections to China has intensified, with documents being requested to clarify his past interactions and affiliations. Walz's history includes teaching in China and multiple visits, during which he expressed positive sentiments about his experiences. However, these ties have become contentious in light of ongoing investigations and the geopolitical climate surrounding U.S.-China relations. Critics argue that such connections could undermine efforts to safeguard American interests against potential threats posed by the Chinese Communist Party. As the investigation unfolds, the Harris-Walz campaign has remained silent on the legislation, raising questions about their stance on national security and foreign influence. The situation highlights the complexities of U.S.-China relations and the challenges faced by politicians navigating these sensitive issues.